Latest trade
Aug 22, 2026 UTC
The most recent trade Polymarket lists for this wallet. Checked Oct 23, 6:20 PM UTC.
Analytics
Royal Harbor A7F1 has made $28.95 on Polymarket.
Share of settled positions that closed in profit.
Not enough settled positions to split gains from losses.
Profit and volume as of 2026-08-26 UTC. Positions and trades are read separately; the Sources tab has their times.
From the trades and settled positions Polymarket lists for this wallet.
Aug 22, 2026 UTC
The most recent trade Polymarket lists for this wallet. Checked Oct 23, 6:20 PM UTC.
$13.52 median trade
Its latest 6 trades covered 1 markets; 100.0% were buys. They run from Aug 15, 2026 UTC to Aug 22, 2026 UTC. A recent sample, not the wallet's full history.
Polymarket returned no open positions for this wallet.
This wallet's markets have not resolved into a category mix in the public profile data yet.
| Market | Side | Size | Price | Notional | When |
|---|---|---|---|---|---|
 FDA approves Daraxonrasib this year?Yes | buy | 138.21 | $0.860 | $118.86 | Aug 22, 2026 UTC |
|
Polymarket public profile
Figures shown from the accepted source observation
2026-08-26 17:41 UTC
Polymarket public position response
0 open positions returned; page complete
2026-10-23 18:20 UTC
Polymarket public trade response
6 recent fills loaded; lifetime history not established
2026-10-23 18:20 UTC
polymarket positions
2 dated points returned
Latest chart point: 2026-08-26 17:41 UTC
Profile checked . Each figure keeps its own source time.
Compare P&L with positions and recorded trades, and check the source dates. A rank or a profitable period alone does not establish repeatable returns.
The largest win was $28.95 on “FDA approves Daraxonrasib this year?” (Yes).
Its most recent trade on record was on 22 Aug 2026. It has traded 1 market. It holds no open positions.
Source: Polymarket's public profile and leaderboard. How to read a trader profile
| buy |
| 10 |
| $0.860 |
| $8.6 |
| Aug 16, 2026 UTC |
| FDA approves Daraxonrasib this year?Yes | buy | 5 | $0.860 | $4.3 | Aug 16, 2026 UTC |
| FDA approves Daraxonrasib this year?Yes | buy | 3.34 | $0.890 | $2.97 | Aug 15, 2026 UTC |
| FDA approves Daraxonrasib this year?Yes | buy | 42.71 | $0.888 | $37.93 | Aug 15, 2026 UTC |
| FDA approves Daraxonrasib this year?Yes | buy | 21.69 | $0.850 | $18.44 | Aug 15, 2026 UTC |